Eric Fedyk

Eric Fedyk

Company: Relay Therapeutics

Job title: Senior Vice President of Strategy


Closing Panel Discussion: Future Directions for BCMA-Directed Therapies 3:00 pm

Pricing/Cost Accessibility changes Is improved trial design needed? How will they be commercialized? What is the ultimate limit of BCMA as a target for myeloma? How will cell therapy infrastructure evolve & how will this effect current situation? Potential limitations to BCMA and how other targets (FcRb5/FcR115, NC28, CS1, SIRH5) could fit in the future…Read more

The Potential of Repurposing BCMA-Targeted Biologics for Treating Autoimmune Diseases 4:30 pm

Understanding the multitude of unmet medical needs which could be addressed with a BCMA-targeted biologic Exploring how the pharmacology of antibodies can be similar in healthy volunteers, autoimmune and oncology patients Learning how antibodies which are effective in treating hematopoietic malignancies have also been re-purposed for the effective treatment of autoimmune diseasesRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.